Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure. It is given after the wound is cleaned with soap and water or povidone-iodine and is followed by a course of rabies vaccine. It is given by injection into the site of the wound and into a muscle. It is not needed in people who have been previously vaccinated against rabies.

The global Rabies Immunoglobulins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

Asia-Pacific is expected to experience the highest growth in the market during the forecast period.

This report aims to provide a comprehensive presentation of the global market for Rabies Immunoglobulins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rabies Immunoglobulins.

Report Scope

The Rabies Immunoglobulins market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rabies Immunoglobulins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Rabies Immunoglobulins manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Rabies Immunoglobulins Market Report

Report Metric	Details
Report Name	Rabies Immunoglobulins Market
Segment by Type	ERIG HRIG
Segment by Application	Category II Exposure Category III Exposure
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	CSL Behring, Grifols, Sanofi, Kamada, Sichuan Yuanda Shuyang, Shuanglin Bio, Weiguang Bio, Shanghai RAAS, Bharat Serum, VINS BioProducts, Tiantan Biological, Hualan Bio, China-Boya, China Biologic Products
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rabies Immunoglobulins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rabies Immunoglobulins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Rabies Immunoglobulins Market report?

Ans: The main players in the Rabies Immunoglobulins Market are CSL Behring, Grifols, Sanofi, Kamada, Sichuan Yuanda Shuyang, Shuanglin Bio, Weiguang Bio, Shanghai RAAS, Bharat Serum, VINS BioProducts, Tiantan Biological, Hualan Bio, China-Boya, China Biologic Products

What are the Application segmentation covered in the Rabies Immunoglobulins Market report?

Ans: The Applications covered in the Rabies Immunoglobulins Market report are Category II Exposure, Category III Exposure

What are the Type segmentation covered in the Rabies Immunoglobulins Market report?

Ans: The Types covered in the Rabies Immunoglobulins Market report are ERIG, HRIG

1 Rabies Immunoglobulins Market Overview

1.1 Product Overview and Scope of Rabies Immunoglobulins

1.2 Rabies Immunoglobulins Segment by Type

1.2.1 Global Rabies Immunoglobulins Market Value Comparison by Type (2024-2030)

1.2.2 ERIG

1.2.3 HRIG

1.3 Rabies Immunoglobulins Segment by Application

1.3.1 Global Rabies Immunoglobulins Market Value by Application: (2024-2030)

1.3.2 Category II Exposure

1.3.3 Category III Exposure

1.4 Global Rabies Immunoglobulins Market Size Estimates and Forecasts

1.4.1 Global Rabies Immunoglobulins Revenue 2019-2030

1.4.2 Global Rabies Immunoglobulins Sales 2019-2030

1.4.3 Global Rabies Immunoglobulins Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Rabies Immunoglobulins Market Competition by Manufacturers

2.1 Global Rabies Immunoglobulins Sales Market Share by Manufacturers (2019-2024)

2.2 Global Rabies Immunoglobulins Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Rabies Immunoglobulins Average Price by Manufacturers (2019-2024)

2.4 Global Rabies Immunoglobulins Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Rabies Immunoglobulins, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Rabies Immunoglobulins, Product Type & Application

2.7 Rabies Immunoglobulins Market Competitive Situation and Trends

2.7.1 Rabies Immunoglobulins Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Rabies Immunoglobulins Players Market Share by Revenue

2.7.3 Global Rabies Immunoglobulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Rabies Immunoglobulins Retrospective Market Scenario by Region

3.1 Global Rabies Immunoglobulins Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Rabies Immunoglobulins Global Rabies Immunoglobulins Sales by Region: 2019-2030

3.2.1 Global Rabies Immunoglobulins Sales by Region: 2019-2024

3.2.2 Global Rabies Immunoglobulins Sales by Region: 2025-2030

3.3 Global Rabies Immunoglobulins Global Rabies Immunoglobulins Revenue by Region: 2019-2030

3.3.1 Global Rabies Immunoglobulins Revenue by Region: 2019-2024

3.3.2 Global Rabies Immunoglobulins Revenue by Region: 2025-2030

3.4 North America Rabies Immunoglobulins Market Facts & Figures by Country

3.4.1 North America Rabies Immunoglobulins Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Rabies Immunoglobulins Sales by Country (2019-2030)

3.4.3 North America Rabies Immunoglobulins Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Rabies Immunoglobulins Market Facts & Figures by Country

3.5.1 Europe Rabies Immunoglobulins Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Rabies Immunoglobulins Sales by Country (2019-2030)

3.5.3 Europe Rabies Immunoglobulins Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Rabies Immunoglobulins Market Facts & Figures by Country

3.6.1 Asia Pacific Rabies Immunoglobulins Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Rabies Immunoglobulins Sales by Country (2019-2030)

3.6.3 Asia Pacific Rabies Immunoglobulins Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Rabies Immunoglobulins Market Facts & Figures by Country

3.7.1 Latin America Rabies Immunoglobulins Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Rabies Immunoglobulins Sales by Country (2019-2030)

3.7.3 Latin America Rabies Immunoglobulins Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Rabies Immunoglobulins Market Facts & Figures by Country

3.8.1 Middle East and Africa Rabies Immunoglobulins Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Rabies Immunoglobulins Sales by Country (2019-2030)

3.8.3 Middle East and Africa Rabies Immunoglobulins Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Rabies Immunoglobulins Sales by Type (2019-2030)

4.1.1 Global Rabies Immunoglobulins Sales by Type (2019-2024)

4.1.2 Global Rabies Immunoglobulins Sales by Type (2025-2030)

4.1.3 Global Rabies Immunoglobulins Sales Market Share by Type (2019-2030)

4.2 Global Rabies Immunoglobulins Revenue by Type (2019-2030)

4.2.1 Global Rabies Immunoglobulins Revenue by Type (2019-2024)

4.2.2 Global Rabies Immunoglobulins Revenue by Type (2025-2030)

4.2.3 Global Rabies Immunoglobulins Revenue Market Share by Type (2019-2030)

4.3 Global Rabies Immunoglobulins Price by Type (2019-2030)

5 Segment by Application

5.1 Global Rabies Immunoglobulins Sales by Application (2019-2030)

5.1.1 Global Rabies Immunoglobulins Sales by Application (2019-2024)

5.1.2 Global Rabies Immunoglobulins Sales by Application (2025-2030)

5.1.3 Global Rabies Immunoglobulins Sales Market Share by Application (2019-2030)

5.2 Global Rabies Immunoglobulins Revenue by Application (2019-2030)

5.2.1 Global Rabies Immunoglobulins Revenue by Application (2019-2024)

5.2.2 Global Rabies Immunoglobulins Revenue by Application (2025-2030)

5.2.3 Global Rabies Immunoglobulins Revenue Market Share by Application (2019-2030)

5.3 Global Rabies Immunoglobulins Price by Application (2019-2030)

6 Key Companies Profiled

6.1 CSL Behring

6.1.1 CSL Behring Corporation Information

6.1.2 CSL Behring Description and Business Overview

6.1.3 CSL Behring Rabies Immunoglobulins Sales, Revenue and Gross Margin (2019-2024)

6.1.4 CSL Behring Rabies Immunoglobulins Product Portfolio

6.1.5 CSL Behring Recent Developments/Updates

6.2 Grifols

6.2.1 Grifols Corporation Information

6.2.2 Grifols Description and Business Overview

6.2.3 Grifols Rabies Immunoglobulins Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Grifols Rabies Immunoglobulins Product Portfolio

6.2.5 Grifols Recent Developments/Updates

6.3 Sanofi

6.3.1 Sanofi Corporation Information

6.3.2 Sanofi Description and Business Overview

6.3.3 Sanofi Rabies Immunoglobulins Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Sanofi Rabies Immunoglobulins Product Portfolio

6.3.5 Sanofi Recent Developments/Updates

6.4 Kamada

6.4.1 Kamada Corporation Information

6.4.2 Kamada Description and Business Overview

6.4.3 Kamada Rabies Immunoglobulins Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Kamada Rabies Immunoglobulins Product Portfolio

6.4.5 Kamada Recent Developments/Updates

6.5 Sichuan Yuanda Shuyang

6.5.1 Sichuan Yuanda Shuyang Corporation Information

6.5.2 Sichuan Yuanda Shuyang Description and Business Overview

6.5.3 Sichuan Yuanda Shuyang Rabies Immunoglobulins Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Sichuan Yuanda Shuyang Rabies Immunoglobulins Product Portfolio

6.5.5 Sichuan Yuanda Shuyang Recent Developments/Updates

6.6 Shuanglin Bio

6.6.1 Shuanglin Bio Corporation Information

6.6.2 Shuanglin Bio Description and Business Overview

6.6.3 Shuanglin Bio Rabies Immunoglobulins Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Shuanglin Bio Rabies Immunoglobulins Product Portfolio

6.6.5 Shuanglin Bio Recent Developments/Updates

6.7 Weiguang Bio

6.6.1 Weiguang Bio Corporation Information

6.6.2 Weiguang Bio Description and Business Overview

6.6.3 Weiguang Bio Rabies Immunoglobulins Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Weiguang Bio Rabies Immunoglobulins Product Portfolio

6.7.5 Weiguang Bio Recent Developments/Updates

6.8 Shanghai RAAS

6.8.1 Shanghai RAAS Corporation Information

6.8.2 Shanghai RAAS Description and Business Overview

6.8.3 Shanghai RAAS Rabies Immunoglobulins Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Shanghai RAAS Rabies Immunoglobulins Product Portfolio

6.8.5 Shanghai RAAS Recent Developments/Updates

6.9 Bharat Serum

6.9.1 Bharat Serum Corporation Information

6.9.2 Bharat Serum Description and Business Overview

6.9.3 Bharat Serum Rabies Immunoglobulins Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Bharat Serum Rabies Immunoglobulins Product Portfolio

6.9.5 Bharat Serum Recent Developments/Updates

6.10 VINS BioProducts

6.10.1 VINS BioProducts Corporation Information

6.10.2 VINS BioProducts Description and Business Overview

6.10.3 VINS BioProducts Rabies Immunoglobulins Sales, Revenue and Gross Margin (2019-2024)

6.10.4 VINS BioProducts Rabies Immunoglobulins Product Portfolio

6.10.5 VINS BioProducts Recent Developments/Updates

6.11 Tiantan Biological

6.11.1 Tiantan Biological Corporation Information

6.11.2 Tiantan Biological Rabies Immunoglobulins Description and Business Overview

6.11.3 Tiantan Biological Rabies Immunoglobulins Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Tiantan Biological Rabies Immunoglobulins Product Portfolio

6.11.5 Tiantan Biological Recent Developments/Updates

6.12 Hualan Bio

6.12.1 Hualan Bio Corporation Information

6.12.2 Hualan Bio Rabies Immunoglobulins Description and Business Overview

6.12.3 Hualan Bio Rabies Immunoglobulins Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Hualan Bio Rabies Immunoglobulins Product Portfolio

6.12.5 Hualan Bio Recent Developments/Updates

6.13 China-Boya

6.13.1 China-Boya Corporation Information

6.13.2 China-Boya Rabies Immunoglobulins Description and Business Overview

6.13.3 China-Boya Rabies Immunoglobulins Sales, Revenue and Gross Margin (2019-2024)

6.13.4 China-Boya Rabies Immunoglobulins Product Portfolio

6.13.5 China-Boya Recent Developments/Updates

6.14 China Biologic Products

6.14.1 China Biologic Products Corporation Information

6.14.2 China Biologic Products Rabies Immunoglobulins Description and Business Overview

6.14.3 China Biologic Products Rabies Immunoglobulins Sales, Revenue and Gross Margin (2019-2024)

6.14.4 China Biologic Products Rabies Immunoglobulins Product Portfolio

6.14.5 China Biologic Products Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Rabies Immunoglobulins Industry Chain Analysis

7.2 Rabies Immunoglobulins Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Rabies Immunoglobulins Production Mode & Process

7.4 Rabies Immunoglobulins Sales and Marketing

7.4.1 Rabies Immunoglobulins Sales Channels

7.4.2 Rabies Immunoglobulins Distributors

7.5 Rabies Immunoglobulins Customers

8 Rabies Immunoglobulins Market Dynamics

8.1 Rabies Immunoglobulins Industry Trends

8.2 Rabies Immunoglobulins Market Drivers

8.3 Rabies Immunoglobulins Market Challenges

8.4 Rabies Immunoglobulins Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Sichuan Yuanda Shuyang

China Biologic Products

List of Tables

Table 1. Global Rabies Immunoglobulins Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Rabies Immunoglobulins Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Rabies Immunoglobulins Market Competitive Situation by Manufacturers in 2023

Table 4. Global Rabies Immunoglobulins Sales (M Units) of Key Manufacturers (2019-2024)

Table 5. Global Rabies Immunoglobulins Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Rabies Immunoglobulins Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Rabies Immunoglobulins Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Rabies Immunoglobulins Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Rabies Immunoglobulins, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Rabies Immunoglobulins, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Rabies Immunoglobulins, Product Type & Application

Table 12. Global Key Manufacturers of Rabies Immunoglobulins, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Rabies Immunoglobulins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Immunoglobulins as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Rabies Immunoglobulins Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Rabies Immunoglobulins Sales by Region (2019-2024) & (M Units)

Table 18. Global Rabies Immunoglobulins Sales Market Share by Region (2019-2024)

Table 19. Global Rabies Immunoglobulins Sales by Region (2025-2030) & (M Units)

Table 20. Global Rabies Immunoglobulins Sales Market Share by Region (2025-2030)

Table 21. Global Rabies Immunoglobulins Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Rabies Immunoglobulins Revenue Market Share by Region (2019-2024)

Table 23. Global Rabies Immunoglobulins Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Rabies Immunoglobulins Revenue Market Share by Region (2025-2030)

Table 25. North America Rabies Immunoglobulins Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Rabies Immunoglobulins Sales by Country (2019-2024) & (M Units)

Table 27. North America Rabies Immunoglobulins Sales by Country (2025-2030) & (M Units)

Table 28. North America Rabies Immunoglobulins Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Rabies Immunoglobulins Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Rabies Immunoglobulins Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Rabies Immunoglobulins Sales by Country (2019-2024) & (M Units)

Table 32. Europe Rabies Immunoglobulins Sales by Country (2025-2030) & (M Units)

Table 33. Europe Rabies Immunoglobulins Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Rabies Immunoglobulins Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Rabies Immunoglobulins Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Rabies Immunoglobulins Sales by Region (2019-2024) & (M Units)

Table 37. Asia Pacific Rabies Immunoglobulins Sales by Region (2025-2030) & (M Units)

Table 38. Asia Pacific Rabies Immunoglobulins Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Rabies Immunoglobulins Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Rabies Immunoglobulins Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Rabies Immunoglobulins Sales by Country (2019-2024) & (M Units)

Table 42. Latin America Rabies Immunoglobulins Sales by Country (2025-2030) & (M Units)

Table 43. Latin America Rabies Immunoglobulins Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Rabies Immunoglobulins Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Rabies Immunoglobulins Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Rabies Immunoglobulins Sales by Country (2019-2024) & (M Units)

Table 47. Middle East & Africa Rabies Immunoglobulins Sales by Country (2025-2030) & (M Units)

Table 48. Middle East & Africa Rabies Immunoglobulins Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Rabies Immunoglobulins Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Rabies Immunoglobulins Sales (M Units) by Type (2019-2024)

Table 51. Global Rabies Immunoglobulins Sales (M Units) by Type (2025-2030)

Table 52. Global Rabies Immunoglobulins Sales Market Share by Type (2019-2024)

Table 53. Global Rabies Immunoglobulins Sales Market Share by Type (2025-2030)

Table 54. Global Rabies Immunoglobulins Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Rabies Immunoglobulins Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Rabies Immunoglobulins Revenue Market Share by Type (2019-2024)

Table 57. Global Rabies Immunoglobulins Revenue Market Share by Type (2025-2030)

Table 58. Global Rabies Immunoglobulins Price (US$/Unit) by Type (2019-2024)

Table 59. Global Rabies Immunoglobulins Price (US$/Unit) by Type (2025-2030)

Table 60. Global Rabies Immunoglobulins Sales (M Units) by Application (2019-2024)

Table 61. Global Rabies Immunoglobulins Sales (M Units) by Application (2025-2030)

Table 62. Global Rabies Immunoglobulins Sales Market Share by Application (2019-2024)

Table 63. Global Rabies Immunoglobulins Sales Market Share by Application (2025-2030)

Table 64. Global Rabies Immunoglobulins Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Rabies Immunoglobulins Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Rabies Immunoglobulins Revenue Market Share by Application (2019-2024)

Table 67. Global Rabies Immunoglobulins Revenue Market Share by Application (2025-2030)

Table 68. Global Rabies Immunoglobulins Price (US$/Unit) by Application (2019-2024)

Table 69. Global Rabies Immunoglobulins Price (US$/Unit) by Application (2025-2030)

Table 70. CSL Behring Corporation Information

Table 71. CSL Behring Description and Business Overview

Table 72. CSL Behring Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. CSL Behring Rabies Immunoglobulins Product

Table 74. CSL Behring Recent Developments/Updates

Table 75. Grifols Corporation Information

Table 76. Grifols Description and Business Overview

Table 77. Grifols Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Grifols Rabies Immunoglobulins Product

Table 79. Grifols Recent Developments/Updates

Table 80. Sanofi Corporation Information

Table 81. Sanofi Description and Business Overview

Table 82. Sanofi Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Sanofi Rabies Immunoglobulins Product

Table 84. Sanofi Recent Developments/Updates

Table 85. Kamada Corporation Information

Table 86. Kamada Description and Business Overview

Table 87. Kamada Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Kamada Rabies Immunoglobulins Product

Table 89. Kamada Recent Developments/Updates

Table 90. Sichuan Yuanda Shuyang Corporation Information

Table 91. Sichuan Yuanda Shuyang Description and Business Overview

Table 92. Sichuan Yuanda Shuyang Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Sichuan Yuanda Shuyang Rabies Immunoglobulins Product

Table 94. Sichuan Yuanda Shuyang Recent Developments/Updates

Table 95. Shuanglin Bio Corporation Information

Table 96. Shuanglin Bio Description and Business Overview

Table 97. Shuanglin Bio Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Shuanglin Bio Rabies Immunoglobulins Product

Table 99. Shuanglin Bio Recent Developments/Updates

Table 100. Weiguang Bio Corporation Information

Table 101. Weiguang Bio Description and Business Overview

Table 102. Weiguang Bio Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Weiguang Bio Rabies Immunoglobulins Product

Table 104. Weiguang Bio Recent Developments/Updates

Table 105. Shanghai RAAS Corporation Information

Table 106. Shanghai RAAS Description and Business Overview

Table 107. Shanghai RAAS Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Shanghai RAAS Rabies Immunoglobulins Product

Table 109. Shanghai RAAS Recent Developments/Updates

Table 110. Bharat Serum Corporation Information

Table 111. Bharat Serum Description and Business Overview

Table 112. Bharat Serum Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Bharat Serum Rabies Immunoglobulins Product

Table 114. Bharat Serum Recent Developments/Updates

Table 115. VINS BioProducts Corporation Information

Table 116. VINS BioProducts Description and Business Overview

Table 117. VINS BioProducts Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. VINS BioProducts Rabies Immunoglobulins Product

Table 119. VINS BioProducts Recent Developments/Updates

Table 120. Tiantan Biological Corporation Information

Table 121. Tiantan Biological Description and Business Overview

Table 122. Tiantan Biological Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Tiantan Biological Rabies Immunoglobulins Product

Table 124. Tiantan Biological Recent Developments/Updates

Table 125. Hualan Bio Corporation Information

Table 126. Hualan Bio Description and Business Overview

Table 127. Hualan Bio Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Hualan Bio Rabies Immunoglobulins Product

Table 129. Hualan Bio Recent Developments/Updates

Table 130. China-Boya Corporation Information

Table 131. China-Boya Description and Business Overview

Table 132. China-Boya Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. China-Boya Rabies Immunoglobulins Product

Table 134. China-Boya Recent Developments/Updates

Table 135. China Biologic Products Corporation Information

Table 136. China Biologic Products Description and Business Overview

Table 137. China Biologic Products Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. China Biologic Products Rabies Immunoglobulins Product

Table 139. China Biologic Products Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Rabies Immunoglobulins Distributors List

Table 143. Rabies Immunoglobulins Customers List

Table 144. Rabies Immunoglobulins Market Trends

Table 145. Rabies Immunoglobulins Market Drivers

Table 146. Rabies Immunoglobulins Market Challenges

Table 147. Rabies Immunoglobulins Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Rabies Immunoglobulins

Figure 2. Global Rabies Immunoglobulins Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Rabies Immunoglobulins Market Share by Type in 2023 & 2030

Figure 4. ERIG Product Picture

Figure 5. HRIG Product Picture

Figure 6. Global Rabies Immunoglobulins Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Rabies Immunoglobulins Market Share by Application in 2023 & 2030

Figure 8. Category II Exposure

Figure 9. Category III Exposure

Figure 10. Global Rabies Immunoglobulins Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global Rabies Immunoglobulins Market Size (2019-2030) & (US$ Million)

Figure 12. Global Rabies Immunoglobulins Sales (2019-2030) & (M Units)

Figure 13. Global Rabies Immunoglobulins Average Price (US$/Unit) & (2019-2030)

Figure 14. Rabies Immunoglobulins Report Years Considered

Figure 15. Rabies Immunoglobulins Sales Share by Manufacturers in 2023

Figure 16. Global Rabies Immunoglobulins Revenue Share by Manufacturers in 2023

Figure 17. The Global 5 and 10 Largest Rabies Immunoglobulins Players: Market Share by Revenue in 2023

Figure 18. Rabies Immunoglobulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 19. Global Rabies Immunoglobulins Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 20. North America Rabies Immunoglobulins Sales Market Share by Country (2019-2030)

Figure 21. North America Rabies Immunoglobulins Revenue Market Share by Country (2019-2030)

Figure 22. United States Rabies Immunoglobulins Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 23. Canada Rabies Immunoglobulins Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Europe Rabies Immunoglobulins Sales Market Share by Country (2019-2030)

Figure 25. Europe Rabies Immunoglobulins Revenue Market Share by Country (2019-2030)

Figure 26. Germany Rabies Immunoglobulins Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. France Rabies Immunoglobulins Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. U.K. Rabies Immunoglobulins Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Italy Rabies Immunoglobulins Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Russia Rabies Immunoglobulins Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Rabies Immunoglobulins Sales Market Share by Region (2019-2030)

Figure 32. Asia Pacific Rabies Immunoglobulins Revenue Market Share by Region (2019-2030)

Figure 33. China Rabies Immunoglobulins Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Japan Rabies Immunoglobulins Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. South Korea Rabies Immunoglobulins Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. India Rabies Immunoglobulins Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Australia Rabies Immunoglobulins Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. China Taiwan Rabies Immunoglobulins Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Indonesia Rabies Immunoglobulins Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Thailand Rabies Immunoglobulins Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Malaysia Rabies Immunoglobulins Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Latin America Rabies Immunoglobulins Sales Market Share by Country (2019-2030)

Figure 43. Latin America Rabies Immunoglobulins Revenue Market Share by Country (2019-2030)

Figure 44. Mexico Rabies Immunoglobulins Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Brazil Rabies Immunoglobulins Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Argentina Rabies Immunoglobulins Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Rabies Immunoglobulins Sales Market Share by Country (2019-2030)

Figure 48. Middle East & Africa Rabies Immunoglobulins Revenue Market Share by Country (2019-2030)

Figure 49. Turkey Rabies Immunoglobulins Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Rabies Immunoglobulins Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. UAE Rabies Immunoglobulins Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Global Sales Market Share of Rabies Immunoglobulins by Type (2019-2030)

Figure 53. Global Revenue Market Share of Rabies Immunoglobulins by Type (2019-2030)

Figure 54. Global Rabies Immunoglobulins Price (US$/Unit) by Type (2019-2030)

Figure 55. Global Sales Market Share of Rabies Immunoglobulins by Application (2019-2030)

Figure 56. Global Revenue Market Share of Rabies Immunoglobulins by Application (2019-2030)

Figure 57. Global Rabies Immunoglobulins Price (US$/Unit) by Application (2019-2030)

Figure 58. Rabies Immunoglobulins Value Chain

Figure 59. Rabies Immunoglobulins Production Process

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Distributors Profiles

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions